AAAAAA

   
Results: 1-8 |
Results: 8
DESIGN AND SYNTHESIS OF M1-SELECTIVE MUSCARINIC AGONISTS - (R)-(-)-(Z)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-(3-(3'-METHOXYPHENYL)-2-PROPYNYL)OXIME MALEATE (CI-1017), A FUNCTIONALLY M1-SELECTIVE MUSCARINIC AGONIST
Authors: TECLE H BARRETT SD LAUFFER DJ AUGELLISZAFRAN C BRANN MR CALLAHAN MJ CAPRATHE BW DAVIS RE DOYLE PD EUBANKS D LIPINISKI W MIRZADEGAN T MOOS WH MORELAND DW NELSON CB PAVIA MR RABY C SCHWARZ RD SPENCER CJ THOMAS AJ JAEN JC
Citation: H. Tecle et al., DESIGN AND SYNTHESIS OF M1-SELECTIVE MUSCARINIC AGONISTS - (R)-(-)-(Z)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-(3-(3'-METHOXYPHENYL)-2-PROPYNYL)OXIME MALEATE (CI-1017), A FUNCTIONALLY M1-SELECTIVE MUSCARINIC AGONIST, Journal of medicinal chemistry, 41(14), 1998, pp. 2524-2536
CRYSTAL-STRUCTURE OF PHENYLMETHANESULFONYL FLUORIDE-TREATED HUMAN CHYMASE AT 1.9-ANGSTROM
Authors: MCGRATH ME MIRZADEGAN T SCHMIDT BF
Citation: Me. Mcgrath et al., CRYSTAL-STRUCTURE OF PHENYLMETHANESULFONYL FLUORIDE-TREATED HUMAN CHYMASE AT 1.9-ANGSTROM, Biochemistry, 36(47), 1997, pp. 14318-14324
CHARACTERIZATION OF THE BINDING OF A POTENT HUMAN TRYPTASE INHIBITOR,APC1167, BY INTRINSIC FLUORESCENCE QUENCHING
Authors: CREGAR LM MOORE WR MIRZADEGAN T TANAKA RD
Citation: Lm. Cregar et al., CHARACTERIZATION OF THE BINDING OF A POTENT HUMAN TRYPTASE INHIBITOR,APC1167, BY INTRINSIC FLUORESCENCE QUENCHING, The FASEB journal, 10(6), 1996, pp. 2333-2333
Z-(+ -)-1-AZABICYCLO [2.2.1]HEPTAN-3-ONE, O-(3-ARYL-2-PROPYNYL) OXIMES AS POTENTIAL M1-SUBTYPE SELECTIVE MUSCARINIC AGONISTS/
Authors: TECLE H JAEN JC AUGELLISZAFRAN C BARRETT SD CAPRATHE BW LAUFFER DJ MIRZADEGAN T MOOS WH MORELAND DW PAVIA MR SCHWARZ RD THOMAS AJ DAVIS RE
Citation: H. Tecle et al., Z-(+ -)-1-AZABICYCLO [2.2.1]HEPTAN-3-ONE, O-(3-ARYL-2-PROPYNYL) OXIMES AS POTENTIAL M1-SUBTYPE SELECTIVE MUSCARINIC AGONISTS/, Bioorganic & medicinal chemistry letters, 5(6), 1995, pp. 631-636
(+ -)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-(3-METHYL-5-ARYL-2-PENTEN-4-YNYL) OXIMES - POTENT MUSCARINIC AGONISTS/
Authors: TECLE H LAUFFER DJ DAVIS RE MIRZADEGAN T MORELAND DW SCHWARZ RD THOMAS AJ RABY C EUBANKS D BRANN MR JAEN JC
Citation: H. Tecle et al., (+ -)-1-AZABICYCLO[2.2.1]HEPTAN-3-ONE, O-(3-METHYL-5-ARYL-2-PENTEN-4-YNYL) OXIMES - POTENT MUSCARINIC AGONISTS/, Bioorganic & medicinal chemistry letters, 5(6), 1995, pp. 637-642
MUTATIONS OF ASPARTATE-103 IN THE HM2 RECEPTOR AND ALTERATIONS IN RECEPTOR-BINDING PROPERTIES OF MUSCARINIC AGONISTS
Authors: SCHWARZ RD SPENCER CJ JAEN JC MIRZADEGAN T MORELAND D TECLE H THOMAS AJ
Citation: Rd. Schwarz et al., MUTATIONS OF ASPARTATE-103 IN THE HM2 RECEPTOR AND ALTERATIONS IN RECEPTOR-BINDING PROPERTIES OF MUSCARINIC AGONISTS, Life sciences, 56(11-12), 1995, pp. 923-929
ARYLENEYNE 1-AZABICYCLO[2.2.1]HEPTAN-3-ONE OXIMES - POTENT MUSCARINICAGONISTS
Authors: TECLE H LAUFFER DJ DAVIS RE MIRZADEGAN T MORELAND DW SCHWARZ RD THOMAS AJ RABY C JAEN JC
Citation: H. Tecle et al., ARYLENEYNE 1-AZABICYCLO[2.2.1]HEPTAN-3-ONE OXIMES - POTENT MUSCARINICAGONISTS, Life sciences, 56(11-12), 1995, pp. 1003-1003
AZULENIC RETINOIDS - NOVEL NONBENZENOID AROMATIC RETINOIDS WITH ANTICANCER ACTIVITY
Authors: ASATO AE PENG A HOSSAIN MZ MIRZADEGAN T BERTRAM JS
Citation: Ae. Asato et al., AZULENIC RETINOIDS - NOVEL NONBENZENOID AROMATIC RETINOIDS WITH ANTICANCER ACTIVITY, Journal of medicinal chemistry, 36(21), 1993, pp. 3137-3147
Risultati: 1-8 |